Opendata, web and dolomites

SIGUEMED SIGNED

The first affordable and easy-to-use IoT system that tracks pill intake with printed circuits technology

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SIGUEMED project word cloud

Explore the words cloud of the SIGUEMED project. It provides you a very rough idea of what is the project "SIGUEMED" about.

network    penetration    00    monthly    base    pharmacies    provides    associate    treatment    time    societal    market    hospitalisations    foil    125    sent    solutions    burden    correct    alerts    sw    wearables    heavy    massive    poly    intake    economic    breach    pack    200    premature    roi    meet    convenient    cascade    sufficient    reports    bluetooth    commercialize    additional    monitoring    connected    solution    pills    track    distributors    personalized    adherence    clients    citizens    smart    combining    350    reached    create    chronic    caretaker    circuits    demands    contact    remind    immigrants    none    platform    dock    commercialization    siguemed    deaths    shape    world    relatives    records    iot    people    extra    place    disruptive    digital    services    ehealth    eu28    patients    pharmacists    first    printed    medication    attempt    authorized    countries    gap    medical    medicated    blister    bridge    sale    unsolved   

Project "SIGUEMED" data sheet

The following table provides information about the project.

Coordinator
INFARMATE ATENCION FARMACEUTICA DOMICILIARIA SL 

Organization address
address: AVENIDA DEL PAPA NEGRO 129 6F
city: MADRID
postcode: 28043
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INFARMATE ATENCION FARMACEUTICA DOMICILIARIA SL ES (MADRID) coordinator 50˙000.00

Map

 Project objective

SIGUEMED is provides the first cost-effective and convenient solution to an unsolved world-wide problem of massive economic and societal impact: the non-adherence to medication of chronic poly-medicated patients. Low medical adherence represents a heavy burden for the EU28 in terms of: - Cost due to extra medical treatment that needs to be given and to additional hospitalisations: estimated at 125,000 M€/year. - Premature deaths that could be avoided with correct adherence to medication: over 200,00 citizens/year Currently there are several solutions that attempt to increase medication adherence, but none of them reaches a sufficient market penetration because they are not useful enough or do not fully meet user demands. To bridge that market gap, we have developed SIGUEMED. SIGUEMED is an IoT eHealth solution aimed at fostering and monitoring medical adherence in a disruptive way. By combining a smart personalized blister pack with printed circuits in its foil (key enabling technology), wearables connected via Bluetooth to the base dock and a SW platform, we are able to remind to the patients intake the time for the intake of pills, and to track if and when this intake has taken place. If there has been any breach in the intake, a cascade of alerts is sent to contact people (relatives, caretaker, pharmacists). Access to track records and monthly reports is also possible. SIGUEMED is especially user-friendly, even for digital immigrants. To commercialize SIGUEMED we will create a network of associated pharmacies, which will be our clients and will shape our network of authorized distributors. They will sale and provide SIGUEMED’s associate services to poly-medicated patients, which are the end-users. After five year of commercialization, we expect to have built a network of more than 10,000 pharmacies in 5 different EU countries and have reached more than 350,000 patients through them. The ROI of the project is of 3.80.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SIGUEMED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SIGUEMED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More